Posted by Michael Wonder on 04 Oct 2016
ICER convenes broad group of stakeholders to inform update to value assessment framework
4 October 2016 - On 30 September 2016, the Institute for Clinical and Economic Review convened a one-day meeting with over 40 health care stakeholders to review the Institute's current value assessment framework and provide input to help inform a planned 2017 update.
The insights discussed at the meeting will inform the 2017 update to the methods that underpin the Institute's evidence reports on new drugs and other health care interventions. Participants in the discussion included patients and representatives from patient organizations, clinical specialty societies, insurers and pharmacy benefit managers, pharmaceutical and biotech companies, and methodologic experts.
